Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Plos Medicine|April 6, 2012
No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trialMarlous L Grijsen, Radjin Steingrover, Ferdinand W N M Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2023
Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time BiasThomas W van der Vaart, Jan M Prins, Cornelis H van Werkhoven, et al.
Plos One|July 25, 2015
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialSteven F L van Lelyveld, Julia Drylewicz, Maaike Krikke, et al.
Open Forum Infectious Diseases|April 3, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.
Thorax|June 10, 2022
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trialInge A H van den Berk, Maadrika M N P Kanglie, Tjitske S R van Engelen, et al.
Pageof 2